Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Gong

Showing results (801-810 of 805) with videos related to

Pageof 81
Sort By:
You have reached the last page of results.This site can display upto 805 results.
Cell Host & Microbe|June 16, 2021
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responsesAlexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responsesAlexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.
Cell Host & Microbe|December 26, 2021
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between dosesAlexandra Tauzin, Shang Yu Gong, Guillaume Beaudoin-Bussières, et al.
Iscience|December 14, 2022
Molecular basis for antiviral activity of two pediatric neutralizing antibodies targeting SARS-CoV-2 Spike RBDYaozong Chen, Jérémie Prévost, Irfan Ullah, et al.
Cell Reports. Medicine|March 2, 2023
A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4<sup>+</sup> T cell profileGérémy Sannier, Alexandre Nicolas, Mathieu Dubé, et al.
Pageof 81

Showing results (801-810 of 805) with videos related to

Sort By:
Pageof 81
You have reached the last page of results.This site can display upto 805 results.
Cell Host & Microbe|June 16, 2021
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responsesAlexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responsesAlexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.
Cell Host & Microbe|December 26, 2021
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between dosesAlexandra Tauzin, Shang Yu Gong, Guillaume Beaudoin-Bussières, et al.
Iscience|December 14, 2022
Molecular basis for antiviral activity of two pediatric neutralizing antibodies targeting SARS-CoV-2 Spike RBDYaozong Chen, Jérémie Prévost, Irfan Ullah, et al.
Cell Reports. Medicine|March 2, 2023
A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4<sup>+</sup> T cell profileGérémy Sannier, Alexandre Nicolas, Mathieu Dubé, et al.
Pageof 81